About Rhoshan Pharmaceuticals
Rhoshan Pharmaceuticals is a private company based in State College, Pennsylvania. It has reported $4,474,950 raised in two offerings on Form D since September 2019. Its chief executive is Hitha Palepu.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 18, 2023 | Sep 22, 2023amended Jul 22, 2026 | $3,099,969of $3.1M target | 4 | $774K | EquityRule 506(b) | Form D/A ↗2 earlier filings |
| Mar 18, 2019 | Sep 23, 2019 | $1,374,981of $1.4M target | 5 | $274K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $4,474,950 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Rhoshan Pharmaceuticals's Form D filed Jul 22, 2026.
Earlier filings also listed Kevin O'Neill (executive officer and director, last listed Sep 2019).